SS

Shaifali Singh

Active Director Director DIN 09224603
DIN 09224603 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Shaifali Singh

Data last updated:

Shaifali Singh is a Director at Sooryam Medi And Healthcare Private Limited (since 2021). The company operates in Healthcare. Sooryam Medi And Healthcare Private Limited reported revenue of ₹31.4 Lakh (FY 2025).

DIN 09224603
Primary Designation Director
Industry Healthcare
First Appointment 02 Jul 2021
Oldest Company Age 5 yrs
Largest company Sooryam Medi And Healthcare Private Limited · ₹31.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jul 20212021₹31.4 Lakh (FY 2025)Active

Board colleagues of Shaifali Singh

Directorship timeline

Open interactive timeline →
Sooryam Medi And Healthcare Private Limited
Premium access

Shareholding and investment profile for Shaifali Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaifali Singh

Shaifali Singh currently holds 1 directorship: Sooryam Medi And Healthcare Private Limited (Director, since 02 Jul 2021, revenue ₹31.4 Lakh (FY 2025)).

Shaifali Singh was first appointed on 02 Jul 2021 as Director at Sooryam Medi And Healthcare Private Limited.

The current boards of Shaifali Singh's companies include Mahabir Singh Tomar (Sooryam Medi And Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available